弓形虫表面抗原 1（SAG1）的研究进展。
Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii.
机构信息
State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China.
出版信息
Parasit Vectors. 2014 Apr 13;7:180. doi: 10.1186/1756-3305-7-180.
Abstract
Toxoplasma gondii is an obligate intracellular parasitic protozoan that has a wide host range and causes a zoonotic parasitosis called toxoplasmosis. This infection causes significant morbidity, costs for care and loss of productivity and suffering. The most effective measures to minimize this parasite's harm to patients are prompt diagnosis and treatment and preventing infection. A parasite surface antigen, SAG1, is considered an important antigen for the development of effective diagnostic tests or subunit vaccines. This review covers several aspects of this antigen, including its gene structure, contribution to host invasion, mechanisms of the immune responses and its applications for diagnosis and vaccine development. This significant progress on this antigen provides foundations for further development of more effective and precise approaches to diagnose toxoplasmosis in the clinic, and also have important implications for exploring novel measures to control toxoplasmosis in the near future.
摘要
刚地弓形虫是一种专性细胞内寄生的原生动物，宿主范围广泛，可引起一种称为弓形虫病的人畜共患寄生虫病。这种感染会导致严重的发病率、医疗费用以及生产力和生活质量的损失。最大限度地减少这种寄生虫对患者的危害的最有效措施是及时诊断和治疗以及预防感染。寄生虫表面抗原 SAG1 被认为是开发有效诊断检测或亚单位疫苗的重要抗原。本综述涵盖了该抗原的几个方面，包括其基因结构、对宿主入侵的贡献、免疫反应机制及其在诊断和疫苗开发中的应用。该抗原的这一重要进展为进一步开发更有效和精确的方法来诊断临床中的弓形虫病提供了基础，也为探索未来控制弓形虫病的新措施提供了重要依据。
相似文献
1
Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii.弓形虫表面抗原 1（SAG1）的研究进展。
Parasit Vectors. 2014 Apr 13;7:180. doi: 10.1186/1756-3305-7-180.
2
Evaluation of immunogenicity and protective effect of DNA vaccine encoding surface antigen1 (SAG1) of Toxoplasma gondii and TLR-5 ligand as a genetic adjuvant against acute toxoplasmosis in BALB/c mice.评价编码刚地弓形虫表面抗原1（SAG1）的DNA疫苗及作为基因佐剂的TLR-5配体对BALB/c小鼠急性弓形虫病的免疫原性和保护作用。
Biologicals. 2019 Nov;62:39-49. doi: 10.1016/j.biologicals.2019.10.002. Epub 2019 Oct 11.
3
Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice.评价编码弓形虫表面抗原 1（SAG1）和 14-3-3 蛋白的 DNA 疫苗在 BALB/c 小鼠中诱导的保护性免疫应答。
Parasit Vectors. 2012 Nov 26;5:273. doi: 10.1186/1756-3305-5-273.
4
Toxoplasma gondii surface antigen 1 (SAG1) as a potential candidate to develop vaccine against toxoplasmosis: A systematic review.刚地弓形虫表面抗原 1（SAG1）作为一种潜在的弓形虫病疫苗候选物：系统评价。
Comp Immunol Microbiol Infect Dis. 2020 Apr;69:101414. doi: 10.1016/j.cimid.2020.101414. Epub 2020 Jan 7.
5
MIC3, a novel cross-protective antigen expressed in Toxoplasma gondii and Neospora caninum.MIC3，一种在刚地弓形虫和犬新孢子虫中表达的新型交叉保护性抗原。
Parasitol Res. 2015 Oct;114(10):3791-9. doi: 10.1007/s00436-015-4609-6. Epub 2015 Jul 5.
6
Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.减毒鼠伤寒沙门氏菌递送的DNA疫苗对小鼠弓形虫感染的保护作用。
Vaccine. 2008 Aug 18;26(35):4541-8. doi: 10.1016/j.vaccine.2008.06.030. Epub 2008 Jun 30.
7
Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.刚地弓形虫：三种由重组 ROP2、ROP4、GRA4 和 SAG1 蛋白组成的三价抗原鸡尾酒对 BALB/c 小鼠慢性弓形虫病的疫苗潜力。
Exp Parasitol. 2012 May;131(1):133-8. doi: 10.1016/j.exppara.2012.02.026. Epub 2012 Mar 14.
8
Immunogenicity and protective efficacy of two recombinant pseudorabies viruses expressing Toxoplasma gondii SAG1 and MIC3 proteins.表达弓形虫 SAG1 和 MIC3 蛋白的两种重组伪狂犬病病毒的免疫原性和保护效力。
Vet Parasitol. 2011 Sep 27;181(2-4):215-21. doi: 10.1016/j.vetpar.2011.04.039. Epub 2011 May 5.
9
Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.刚地弓形虫：用编码SAG1、GRA2、GRA7和ROP16的T细胞和B细胞表位的DNA疫苗进行接种可引发小鼠对急性弓形虫病的保护作用。
Vaccine. 2015 Nov 27;33(48):6757-62. doi: 10.1016/j.vaccine.2015.10.077. Epub 2015 Oct 27.
10
Transgenic Eimeria tenella as a vaccine vehicle: expressing TgSAG1 elicits protective immunity against Toxoplasma gondii infections in chickens and mice.转 Eimeria tenella 作为疫苗载体：表达 TgSAG1 可引发鸡和小鼠对弓形虫感染的保护性免疫。
Sci Rep. 2016 Jul 8;6:29379. doi: 10.1038/srep29379.
引用本文的文献
1
Design of a Multi-epitope Antigen for Toxoplasmosis Diagnosis: An Immunoinformatics Approach.用于弓形虫病诊断的多表位抗原设计：一种免疫信息学方法
Acta Parasitol. 2025 Sep 9;70(5):192. doi: 10.1007/s11686-025-01132-w.
2
Surface antigen SAG1 mediates fitness and host cell attachment in IFNγ-stimulated cells.表面抗原SAG1在IFNγ刺激的细胞中介导适应性和宿主细胞附着。
Infect Immun. 2025 Aug 12;93(8):e0001025. doi: 10.1128/iai.00010-25. Epub 2025 Jul 3.
3
Design and immunological evaluation of a multi-epitope vaccine candidate against incorporating MIC13, GRA1, and SAG1 antigens in BALB/c mice.一种针对在BALB/c小鼠中整合MIC13、GRA1和SAG1抗原的多表位候选疫苗的设计与免疫学评估。
Food Waterborne Parasitol. 2025 Jun 2;40:e00269. doi: 10.1016/j.fawpar.2025.e00269. eCollection 2025 Sep.
4
Antibody Responses to EBV and Toxoplasma and Their Genetic Links to Guillain-Barré Syndrome: A Mendelian Randomization Study.针对EB病毒和弓形虫的抗体反应及其与吉兰-巴雷综合征的遗传联系：一项孟德尔随机化研究
Brain Behav. 2025 Feb;15(2):e70298. doi: 10.1002/brb3.70298.
5
Novel antibodies detect nucleocytoplasmic O-fucose in protist pathogens, cellular slime molds, and plants.新型抗体可检测原生生物病原体、细胞黏菌和植物中的核质O-岩藻糖。
mSphere. 2025 Feb 25;10(2):e0094524. doi: 10.1128/msphere.00945-24. Epub 2025 Feb 6.
6
Specific Cell Targeting by Displaying Functional Single-Chain Variable Fragment as a Novel Strategy; A Proof of Principle.展示功能单链可变片段实现特定细胞靶向：一种新策略的原理验证。
Cells. 2024 Jun 4;13(11):975. doi: 10.3390/cells13110975.
7
Recombinant production of SAG1 fused with xylanase in Pichia pastoris induced higher protective immunity against Eimeria tenella infection in chicken.毕赤酵母中表达与木聚糖酶融合的 SAG1 可诱导鸡对柔嫩艾美耳球虫感染产生更高的保护免疫。
Microb Biotechnol. 2024 Mar;17(3):e14447. doi: 10.1111/1751-7915.14447.
8
Stable expression of mucin glycoproteins GP40 and GP15 of Cryptosporidium parvum in Toxoplasma gondii.稳定表达隐孢子虫微小隐孢子虫糖蛋白 GP40 和 GP15 于刚地弓形虫中。
Parasit Vectors. 2024 Feb 15;17(1):65. doi: 10.1186/s13071-024-06159-y.
9
Vaccine Design and Expression of the Multi-Component Protein Candidate against the Parasite from MIC13, GRA1, and SAG1 Antigens.针对来自MIC13、GRA1和SAG1抗原的寄生虫的多组分蛋白候选物的疫苗设计与表达
Iran J Parasitol. 2023 Jul-Sep;18(3):301-312. doi: 10.18502/ijpa.v18i3.13753.
10
scDual-Seq of -infected mouse BMDCs reveals heterogeneity and differential infection dynamics.scDual-Seq 分析感染小鼠 BMDC 揭示了异质性和差异感染动力学。
Front Immunol. 2023 Jul 27;14:1224591. doi: 10.3389/fimmu.2023.1224591. eCollection 2023.
本文引用的文献
1
Comparative efficacy of a multi-epitope DNA vaccine via intranasal, peroral, and intramuscular delivery against lethal Toxoplasma gondii infection in mice.经鼻腔、口服和肌肉途径递送多表位 DNA 疫苗对致死性弓形虫感染小鼠的比较疗效。
Parasit Vectors. 2014 Mar 31;7:145. doi: 10.1186/1756-3305-7-145.
2
A comparative study of Toxoplasma gondii seroprevalence in three healthy Chinese populations detected using native and recombinant antigens.应用天然和重组抗原检测三种健康中国人群中弓形虫血清流行率的比较研究。
Parasit Vectors. 2013 Aug 20;6(1):241. doi: 10.1186/1756-3305-6-241.
3
Identification and characterization of Toxoplasma gondii aspartic protease 1 as a novel vaccine candidate against toxoplasmosis.鉴定和表征刚地弓形虫天冬氨酸蛋白酶 1 作为一种新型弓形虫病疫苗候选物。
Parasit Vectors. 2013 Jun 14;6:175. doi: 10.1186/1756-3305-6-175.
4
Screening and identification of novel B cell epitopes of Toxoplasma gondii SAG1.弓形虫 SAG1 新 B 细胞表位的筛选与鉴定。
Parasit Vectors. 2013 Apr 30;6:125. doi: 10.1186/1756-3305-6-125.
5
Evaluation of a commercial ELISA kit for detection of antibodies against Toxoplasma gondii in serum, plasma and meat juice from experimentally and naturally infected sheep.评价一种用于检测实验感染和自然感染绵羊血清、血浆和肉汁中抗弓形虫抗体的商业 ELISA 试剂盒。
Parasit Vectors. 2013 Apr 5;6:85. doi: 10.1186/1756-3305-6-85.
6
Compound DNA vaccine encoding SAG1/ SAG3 with A2/B subunit of cholera toxin as a genetic adjuvant protects BALB/c mice against Toxoplasma gondii.编码 SAG1/SAG3 与霍乱毒素 A2/B 亚单位的复合 DNA 疫苗作为一种遗传佐剂可保护 BALB/c 小鼠免受弓形虫感染。
Parasit Vectors. 2013 Mar 13;6:63. doi: 10.1186/1756-3305-6-63.
7
Induction of long-lasting protective immunity against Toxoplasma gondii in BALB/c mice by recombinant surface antigen 1 protein encapsulated in poly (lactide-co-glycolide) microparticles.聚乳酸-共乙醇酸微球包裹重组表面抗原 1 蛋白诱导 BALB/c 小鼠产生长效保护性免疫
Parasit Vectors. 2013 Feb 11;6:34. doi: 10.1186/1756-3305-6-34.
8
Seroprevalence and risk factors for Toxoplasmosis in HIV infected and non-infected individuals in Bahir Dar, Northwest Ethiopia.埃塞俄比亚西北部巴赫达尔地区 HIV 感染和未感染个体弓形体病的血清流行率及危险因素。
Parasit Vectors. 2013 Jan 16;6(1):15. doi: 10.1186/1756-3305-6-15.
9
Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice.评价编码弓形虫表面抗原 1（SAG1）和 14-3-3 蛋白的 DNA 疫苗在 BALB/c 小鼠中诱导的保护性免疫应答。
Parasit Vectors. 2012 Nov 26;5:273. doi: 10.1186/1756-3305-5-273.
10
Seroprevalence of Toxoplasma gondii infection in slaughtered chickens, ducks, and geese in Shenyang, northeastern China.中国东北地区沈阳市屠宰鸡、鸭和鹅中弓形虫感染的血清流行率。
Parasit Vectors. 2012 Oct 18;5:237. doi: 10.1186/1756-3305-5-237.
Zotero 插件